Tomoharu Dohi

Impact of Diabetes on the Efficacy of Low-Voltage Area Ablation for Persistent Atrial Fibrillation: A Subanalysis of the SUPPRESS-AF Trial.

Journal: Journal of the American Heart Association

Published: June 15, 2026

Drug-coated versus conventional balloons for side branch treatment in coronary bifurcation lesions: an optical coherence tomography substudy of the OCVC-BIF randomised trial.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: May 27, 2026

Drug-coated versus conventional balloons for side branch treatment in coronary bifurcation lesions: an optical coherence tomography substudy of the OCVC-BIF randomised trial.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: May 27, 2026

Efficacy of Low-Voltage Area Ablation Across Substrate Size in Persistent Atrial Fibrillation: A Post Hoc Analysis of the SUPPRESS-AF Randomized Trial.

Journal: Journal of the American Heart Association

Published: May 25, 2026

ALID score for treatment-effect heterogeneity of adjunctive low-voltage area ablation in persistent atrial fibrillation: A post hoc analysis of SUPPRESS-AF.

Journal: International journal of cardiology

Published: May 24, 2026

Complete Low-Voltage Area Ablation in Persistent Atrial Fibrillation　- Post Hoc Subanalysis of the SUPPRESS-AF Trial.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: May 06, 2026

Differential Impact of Low Voltage Area Radiofrequency Ablation on Recurrence of Atrial Fibrillation Versus Atrial Tachycardia in Patients With Persistent Atrial Fibrillation.

Journal: Circulation. Arrhythmia and electrophysiology

Published: April 01, 2026

Win Ratio Analysis of an Extensive Ablation Strategy in Patients With Persistent Atrial Fibrillation: Insights From the EARNEST-PVI Randomized Trial.

Journal: Circulation. Arrhythmia and electrophysiology

Published: March 31, 2026

Concomitant Diabetes Mellitus Diminishes the Efficacy of Left Atrial Additional Ablation Following Pulmonary Vein Isolation　- A Subanalysis of the EARNEST-PVI Trial.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: February 08, 2026

Left atrial functional deterioration after beyond-pulmonary vein isolation strategy predominantly consisting of linear ablation: Insights from the EARNEST-PVI Trial.

Journal: International journal of cardiology

Published: November 02, 2025

Win ratio analysis of low-voltage area ablation in persistent atrial fibrillation: sub-analysis of SUPPRESS-AF.

Journal: European heart journal open

Published: October 23, 2025

Efficacy of Low-Voltage-Area Ablation Is Enhanced in Patients With Advanced Left Atrial Enlargement: A Subanalysis of the SUPPRESS-AF Trial.

Journal: Circulation. Arrhythmia and electrophysiology

Published: September 26, 2025

Impact of Diabetes on the Efficacy of Low-Voltage Area Ablation for Persistent Atrial Fibrillation: A Subanalysis of the SUPPRESS-AF Trial.

Impact of Diabetes on the Efficacy of Low-Voltage Area Ablation for Persistent Atrial Fibrillation: A Subanalysis of the SUPPRESS-AF Trial.

Drug-coated versus conventional balloons for side branch treatment in coronary bifurcation lesions: an optical coherence tomography substudy of the OCVC-BIF randomised trial.

Drug-coated versus conventional balloons for side branch treatment in coronary bifurcation lesions: an optical coherence tomography substudy of the OCVC-BIF randomised trial.

Drug-coated versus conventional balloons for side branch treatment in coronary bifurcation lesions: an optical coherence tomography substudy of the OCVC-BIF randomised trial.

Drug-coated versus conventional balloons for side branch treatment in coronary bifurcation lesions: an optical coherence tomography substudy of the OCVC-BIF randomised trial.

Efficacy of Low-Voltage Area Ablation Across Substrate Size in Persistent Atrial Fibrillation: A Post Hoc Analysis of the SUPPRESS-AF Randomized Trial.

Efficacy of Low-Voltage Area Ablation Across Substrate Size in Persistent Atrial Fibrillation: A Post Hoc Analysis of the SUPPRESS-AF Randomized Trial.

ALID score for treatment-effect heterogeneity of adjunctive low-voltage area ablation in persistent atrial fibrillation: A post hoc analysis of SUPPRESS-AF.

ALID score for treatment-effect heterogeneity of adjunctive low-voltage area ablation in persistent atrial fibrillation: A post hoc analysis of SUPPRESS-AF.

Complete Low-Voltage Area Ablation in Persistent Atrial Fibrillation - Post Hoc Subanalysis of the SUPPRESS-AF Trial.

Complete Low-Voltage Area Ablation in Persistent Atrial Fibrillation - Post Hoc Subanalysis of the SUPPRESS-AF Trial.

Differential Impact of Low Voltage Area Radiofrequency Ablation on Recurrence of Atrial Fibrillation Versus Atrial Tachycardia in Patients With Persistent Atrial Fibrillation.

Differential Impact of Low Voltage Area Radiofrequency Ablation on Recurrence of Atrial Fibrillation Versus Atrial Tachycardia in Patients With Persistent Atrial Fibrillation.

Win Ratio Analysis of an Extensive Ablation Strategy in Patients With Persistent Atrial Fibrillation: Insights From the EARNEST-PVI Randomized Trial.

Win Ratio Analysis of an Extensive Ablation Strategy in Patients With Persistent Atrial Fibrillation: Insights From the EARNEST-PVI Randomized Trial.

Concomitant Diabetes Mellitus Diminishes the Efficacy of Left Atrial Additional Ablation Following Pulmonary Vein Isolation - A Subanalysis of the EARNEST-PVI Trial.

Concomitant Diabetes Mellitus Diminishes the Efficacy of Left Atrial Additional Ablation Following Pulmonary Vein Isolation - A Subanalysis of the EARNEST-PVI Trial.

Left atrial functional deterioration after beyond-pulmonary vein isolation strategy predominantly consisting of linear ablation: Insights from the EARNEST-PVI Trial.

Left atrial functional deterioration after beyond-pulmonary vein isolation strategy predominantly consisting of linear ablation: Insights from the EARNEST-PVI Trial.

Win ratio analysis of low-voltage area ablation in persistent atrial fibrillation: sub-analysis of SUPPRESS-AF.

Win ratio analysis of low-voltage area ablation in persistent atrial fibrillation: sub-analysis of SUPPRESS-AF.

Efficacy of Low-Voltage-Area Ablation Is Enhanced in Patients With Advanced Left Atrial Enlargement: A Subanalysis of the SUPPRESS-AF Trial.

Efficacy of Low-Voltage-Area Ablation Is Enhanced in Patients With Advanced Left Atrial Enlargement: A Subanalysis of the SUPPRESS-AF Trial.

Complete Low-Voltage Area Ablation in Persistent Atrial Fibrillation　- Post Hoc Subanalysis of the SUPPRESS-AF Trial.

Complete Low-Voltage Area Ablation in Persistent Atrial Fibrillation　- Post Hoc Subanalysis of the SUPPRESS-AF Trial.

Concomitant Diabetes Mellitus Diminishes the Efficacy of Left Atrial Additional Ablation Following Pulmonary Vein Isolation　- A Subanalysis of the EARNEST-PVI Trial.

Concomitant Diabetes Mellitus Diminishes the Efficacy of Left Atrial Additional Ablation Following Pulmonary Vein Isolation　- A Subanalysis of the EARNEST-PVI Trial.